Unapproved use of high-dose combined pills in Japan: A community study on prevalence and health characteristics of the users

Preventive Medicine

Volumn 26, Issue 4, 1997, Pages 565-569

  Nagata, Chisato ^a   Matsushita, Yoko ^a   Inaba, Shizuyo ^a   Kawakami, Norito ^a   Shimizu, Hiroyuki ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular disease; Japan; Oral contraceptives; Prevalence; Smoking

Indexed keywords

ANTIOXIDANT; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; DIET; DRUG USE; FEMALE; HUMAN; JAPAN; LIFESTYLE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; PREVALENCE; PRIORITY JOURNAL; SMOKING;

EID: 0031193379     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.1997.0176     Document Type: Article

References (25)

1. Russel-Briefel R, Ezzati T, Perman J. Prevalence and trends in oral contraceptive use in premenopausal females ages 12-54, United States 1971-1980. Am J Public Health. 75:1985;1173-1176.
2. Mosher W D, Pratt W F. Contraceptive use in the United States, 1973-88. Patient Educ Counsel. 16:1990;163-174.
3. Riphagen F E, Lehert P. A survey of contraception in five West European countries. J Biosoc Sci. 21:1989;23-46.
4. Gaspard U J, Lefebvre P J. Clinical aspects of relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease. Am J Obstet Gynecol. 163:1990;334-343.
5. Inman W HW, Vessey M P, Westerholm B, Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives: a report to the Committee on Safety of Drugs. Br Med J. 2:1970;203-209.
6. Botter L E, Boman G, Eklund G, Westerholm B. Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content. Lancet. ii:1980;1097-1101.
7. Meade T W, Greenberg G, Thompson S G. Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-μg oestrogen preparations. Br Med J. 10:1980;1157-1161.
8. Jitsukawa M, Djerassi C. Birth control in Japan: realities and prognosis. Science. 265:1994;1048-1051.
9. Kobayashi T. Oral contraceptive pill. Obstet Gynecol Ther. 68:1994;433-439.
10. Yamauchi M. Japan bans pill through fear of HIV. Br Med J. 304:1992;863.
11. Kobayashi T. New oral contraceptives (low-dose pill). Obstet Gynecol Ther. 61:1990;682-686.
12. Oliver M F. Oral contraceptives and myocardial infarction. Br Med J. 2:1970;210-213.
13. Stadel B V. Oral contraceptives and cardiovascular disease (second of two parts). N Engl J Med. 305:1981;672-677.
14. Layde O M, Beral V, Kay C R. Further analyses of mortality in oral contraceptive users: Royal College of General Practitioner's Oral Contraception Study. Lancet. i:1981;541-546.
15. H, Shimizu, 1966, A basic report on Takayama Study, Department of Public Health, Gifu University School of Medicine, Gifu, Japan.
16. Yanagibori R, Aoki K, Suzuki Y, Gunji A. Evaluation of methods for measuring daily physical activity in terms of energy expenditure. Jpn J Public Health. 38:1991;483-491.
17. Willett W, Stampfer M J. Implications of total energy intake for epidemiologic analyses. Nutritional epidemiology. 1990;Oxford Univ. Press, Oxford. p. 245-271.
18. SAS Institute, 1994, SAS user's guide, SAS Institute, Cary, NC.
19. Mainichi Newspaper. 1992 May 11;12-13.
20. Mainichi Newspaper. 1994 July 27;6-7.
21. Singh R B, Rastogi S S, Sircar A R, Mehta P J, Sharma K K. Dietary strategies for risk-factor modification to prevent cardiovascular diseases. Nutrition. 7:1991;1-5.
22. Stampfer M J, Hennekens C H, Manson J E, Colditz G A, Rosner B, Willett W C, Willet W C. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 328:1993;1444-1449.
23. Frei B. Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation. Crit Rev Food Sci Nutr. 35:1995;83-98.
24. Startwell P E. Oral contraceptives and thromboembolism: a further report. Am J Epidemiol. 94:1971;192-201.
25. Sharpe C R. Smoking among oral contraceptive users in Quebec in 1987. J Clin Epidemiol. 47:1994;313-323.